Pharmacopsychiatry 1996; 29(1): 27-30
DOI: 10.1055/s-2007-979538
Original Paper

© Georg Thieme Verlag Stuttgart · New York

Citalopram in the Treatment of Alcoholism: a Double-blind Placebo-controlled Study

J. Tiihonen1 , O.-P. Ryynänen2 , J. Kauhanen3 , H. P. A. Hakola4 , M. Salaspuro5
  • 1University of Kuopio, Department of Forensic Psychiatry, Niuvanniemi Hospital, Kuopio, Finland
  • 2University of Kuopio, Department of Community Health and General Practice, Kuopio, Finland
  • 3University of Kuopio, Department of Community Health and General Practice, Kuopio, Finland
  • 4University of Kuopio, Department of Forensic Psychiatry, Niuvanniemi Hospital, Kuopio, Finland
  • 5University of Helsinki, Research Unit of Alcohol Diseases, Helsinki, Finland
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. April 2007 (online)

Preview

Abstract

The effect of citalopram and placebo in the treatment of alcoholism was studied in a sample of 62 patients with a follow-up period of four months. The results imply that the new 5-HT re-uptake inhibitor citalopram is significantly more effective than placebo in the treatment of alcoholism. The present study indicates that even severe alcoholism may be treated effectively with a generally available psychopharmacological agent.